Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Asieris Approved to Start Global Phase III Trials of Cervical Lesion Treatment

Evive Bio Reports Positive Late-Stage Results on Neutropenia Treatment

Sinovac Approved to Start Phase III Trial of COVID-19 Vaccine in Brazil

Hua Reports Positive Interim Results from Novel Type 2 Diabetes Candidate

China Consortium Starts Phase I Trial of mRNA Vaccine for COVID-19

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China